These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 6188916)

  • 1. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
    Svendsen TL; Trap-Jensen J; Carlsen JE; McNair A
    Am Heart J; 1985 May; 109(5 Pt 2):1145-50. PubMed ID: 2859778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
    Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
    Leclercq JF; Rosengarten MD; Kural S; Attuel P; Coumel P
    Eur J Cardiol; 1981; 12(6):367-75. PubMed ID: 6113145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P; Rost R; Reinke A; Nagel N; Merten U
    Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additional properties of beta adrenoceptor blocking drugs.
    Prichard BN; Tomlinson B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some metabolic responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):402-4. PubMed ID: 7904930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
    Murthy VS; Hwang TF; Wurm R; Zagar ME; Keith RA; Kau ST; Salama AI; Giles RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):249-55. PubMed ID: 2563289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
    Golf S; Hansson V
    Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.